KRT14 and neoplasm: Tumor initiator DMBA and tumor promoter TPA were administered topically and sequentially in WT and Lgals7−/− mice, and in Tg46 mice, which constitutively express Gal-7 under the K14 promoter (Supplementary Fig. S1B).